These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 38350499

  • 1. Intranasal delivery of thin-film freeze-dried monoclonal antibodies using a powder nasal spray system.
    Yu YS, Xu H, AboulFotouh K, Williams G, Suman J, Sahakijpijarn S, Cano C, Warnken ZN, Wu KC, Williams RO, Cui Z.
    Int J Pharm; 2024 Mar 25; 653():123892. PubMed ID: 38350499
    [Abstract] [Full Text] [Related]

  • 2. Feasibility of intranasal delivery of thin-film freeze-dried, mucoadhesive vaccine powders.
    Yu YS, AboulFotouh K, Xu H, Williams G, Suman J, Cano C, Warnken ZN, Wu KC, Williams RO, Cui Z.
    Int J Pharm; 2023 Jun 10; 640():122990. PubMed ID: 37127138
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development of favipiravir dry powders for intranasal delivery: An integrated cocrystal and particle engineering approach via spray freeze drying.
    Wong SN, Li S, Low KH, Chan HW, Zhang X, Chow S, Hui B, Chow PCY, Chow SF.
    Int J Pharm; 2024 Mar 25; 653():123896. PubMed ID: 38346602
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
    Li X, Vogt FG, Hayes D, Mansour HM.
    J Aerosol Med Pulm Drug Deliv; 2014 Apr 25; 27(2):81-93. PubMed ID: 24502451
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of Stability Constraints in the Particle Engineering of an Inhaled Monoclonal Antibody Dried Powder.
    Brunaugh AD, Ding L, Wu T, Schneider M, Khalaf R, Smyth HDC.
    J Pharm Sci; 2022 Feb 25; 111(2):403-416. PubMed ID: 34453927
    [Abstract] [Full Text] [Related]

  • 14. Development and testing of particulate formulations for the nasal delivery of antibodies.
    Kaye RS, Purewal TS, Alpar OH.
    J Control Release; 2009 Apr 17; 135(2):127-35. PubMed ID: 19059291
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmaceutical dry powders of small molecules prepared by thin-film freezing and their applications - A focus on the physical and aerosol properties of the powders.
    Praphawatvet T, Cui Z, Williams RO.
    Int J Pharm; 2022 Dec 15; 629():122357. PubMed ID: 36332829
    [Abstract] [Full Text] [Related]

  • 19. Spray freeze drying for dry powder inhalation of nanoparticles.
    Ali ME, Lamprecht A.
    Eur J Pharm Biopharm; 2014 Aug 15; 87(3):510-7. PubMed ID: 24657824
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.